Novartis Investigative Site

Yanagawa, Fukuoka 832-0059

0 studies enrolling now · 4 studies all time

What they study most

Asthma, Pulmonary Disease, Chronic Obstructive

Studies at this site

• Dose-range Finding Efficacy and Safety Study for QBW251 in COPD Patients — Completed
• Dose Finding Study for QAW039 in Asthma — Completed
• Study of Safety of QAW039 in Patients With Asthma Inadequately Controlled on Standard-of-care Asthma Treatment — Stopped early
• A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma — Completed